Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

Invigor Medical vs ElleS

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade B+ · #8

Invigor Medical

Value shoppers who want competitive pricing on both molecules plus a wider wellness/hormone program on one account.

Visit Invigor Medical
VS
Grade C · #415

ElleS

Shoppers wanting compounded GLP-1 (including oral capsules) within a broad telehealth menu.

Visit ElleS

The verdict

Winner · Invigor MedicalGrade B+ vs C

Invigor Medical takes it, leading the Cost-Efficiency Index 88 to 46. Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog. ElleS still earns a CShoppers wanting compounded GLP-1 (including oral capsules) within a broad telehealth menu.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Invigor Medical.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

86
45

Price Transparency

84
54

Nationwide Access

78
24

Formulation Options

82
51

Clinical Oversight

86
79

Contract Flexibility

87
20

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecInvigor MedicalElleS
Cost-Efficiency Index88/10046/100
Semaglutide / mo$199/moNot disclosed
Tirzepatide / mo$339/moNot disclosed
Semaglutide / yr (modeled)$2,388
Tirzepatide / yr (modeled)$4,068
CoverageNot disclosedCoverage not published
Oral / sublingualNoYes
Brand-name accessCompounded onlyCompounded only
Rank on the board#8#415

Invigor Medical

88/100

Where the value is

  • Competitive mid-market pricing on both semaglutide and tirzepatide
  • Long-running operator with a broad catalog that can consolidate spend
  • Both molecules published up front for easy cost modeling

The tradeoffs

  • Does not publish an explicit states-served list, so access is a variable in the model
  • Compounded only
Visit Invigor Medical

Full Invigor Medical review →

ElleS

46/100

Where the value is

  • Compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus microdose options
  • Packages bundle the telehealth visit, medication, and shipping; Registered Dietitian support included
  • Full legal suite published — Terms, Privacy Policy, Privacy Practices, and Medical Consent

The tradeoffs

  • Pricing not shown publicly — products and costs appear only after the intake flow
  • Sold as 3- and 6-month packages rather than simple monthly plans
Visit ElleS

Full ElleS review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons